An Individualized Risk Calculator for Research in Prodromal Psychosis
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Approximately 20%-35% of individuals 12-35 years old who meet criteria for a prodromal risk syndrome convert to psychosis within 2 years. However, this estimate ignores the fact that clinical high-risk cases vary considerably in risk. The authors sought to create a risk calculator, based on profiles of risk indicators, that can ascertain the probability of conversion to psychosis in individual patients. METHOD: The study subjects were 596 clinical high-risk participants from the second phase of the North American Prodrome Longitudinal Study who were followed up to the time of conversion to psychosis or last contact (up to 2 years). The predictors examined were limited to those that are supported by previous studies and are readily obtainable in general clinical settings. Time-to-event regression was used to build a multivariate model predicting conversion, with internal validation using 1,000 bootstrap resamples. RESULTS: The 2-year probability of conversion to psychosis was 16%. Higher levels of unusual thought content and suspiciousness, greater decline in social functioning, lower verbal learning and memory performance, slower speed of processing, and younger age at baseline each contributed to individual risk for psychosis. Stressful life events, trauma, and family history of schizophrenia were not significant predictors. The multivariate model achieved a concordance index of 0.71 and, as reported in an article by Carrión et al., published concurrently with this one, was validated in an independent external data set. The results are instantiated in a web-based risk prediction tool envisioned to be most useful in research protocols involving the psychosis prodrome. CONCLUSIONS: A risk calculator comparable in accuracy to those for cardiovascular disease and cancer is available to predict individualized conversion risks in newly ascertained clinical high-risk cases. Given that the risk calculator can be validly applied only for patients who screen positive on the Structured Clinical Interview for Psychosis Risk Syndromes, which requires training to administer, its most immediate uses will be in research on psychosis risk factors and in research-driven clinical (prevention) trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“clinical [81], cognitive [82], and neuroimaging measures [83] constitute possible biomarkers that significantly increase accuracy for predicting clinical outcomes in CHR-P participants”
From Towards a youth mental health paradigm: a perspective and roadmap (2023) · cites this paper as [81]
In the citing paper
“596 (18.5, US); 0.71 (C- index) 291”
From Preventive psychiatry: a blueprint for improving the mental health of young people (2021) · cites this paper as [291]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Lee, T. H., Marcantonio, E. R., Mangione, C. M., Thomas, E. J., Polanczyk, C. A., Cook, E. F., Sugarbaker, D. J., Donaldson, M. C., Poss, R., Ho, K. K. L., et al. (1999) · Circulation · doi:10.1161/01.cir.100.10.1043 · Cited by 3,771
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573
Uno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535 · cited 1×
“5 (no discrimination) to 1 (perfect discrimination), but tailored for censored data (30).”
BackgroundThe Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483 · cited 4×
“Greater severity of SIPS items P1 and P2 (Unusual Thought Content and Suspiciousness) are strongly predictive of psychosis in CHR samples (3, 4).”
BackgroundResultInfluentialSelf-citationPredicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Fusar-Poli, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1472 · Cited by 1,361
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269 · cited 4×
“Greater severity of SIPS items P1 and P2 (unusual thought content and suspiciousness) are strongly predictive of psychosis in clinical high-risk samples (3, 4).”
BackgroundInfluentialSelf-citationExemplification of a Method for Scaling Life Events: The PERI Life Events Scale
Dohrenwend, B. S., Askenasy, A. R., Krasnoff, L., & Dohrenwend, B. P. (1978) · Journal of Health and Social Behavior · doi:10.2307/2136536 · Cited by 1,211 · cited 2×
“Proper training in the administration and scoring of the other measures included in the risk calculator (i.e., Symbol-Coding, HVLT-R, GSF-S, RILES, CTAS) is also required.”
MethodMcGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056
Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Research works printed but not linked: 2
- First M, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition
- Brandt J, 1998, Hopkins Verbal Learning Test–Revised (HVLT-R)
Cited by
Machine Learning Approaches for Clinical Psychology and Psychiatry
Dwyer, D. B., Falkai, P., & Koutsouleris, N. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045037 · Cited by 966
Preventive psychiatry: a blueprint for improving the mental health of young people
Fusar‐Poli, P., Correll, C. U., Arango, C., Berk, M., Patel, V., & Ioannidis, J. P. A. (2021) · World Psychiatry · doi:10.1002/wps.20869 · Cited by 497
Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry
McGorry, P. D., Hartmann, J. A., Spooner, R., & Nelson, B. (2018) · World Psychiatry · doi:10.1002/wps.20514 · Cited by 488
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention
Fusar-Poli, P., Salazar de Pablo, G., Correll, C. U., Meyer-Lindenberg, A., Millan, M. J., Borgwardt, S., Galderisi, S., Bechdolf, A., Pfennig, A., Kessing, L. V., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4779 · Cited by 476
Moving From Static to Dynamic Models of the Onset of Mental Disorder: A Review
Nelson, B., McGorry, P. D., Wichers, M., Wigman, J. T. W., & Hartmann, J. A. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0001 · Cited by 376
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Salazar de Pablo, G., Radua, J., Pereira, J., Bonoldi, I., Arienti, V., Besana, F., Soardo, L., Cabras, A., Fortea, L., Catalan, A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0830 · Cited by 375
Koutsouleris, N., Kambeitz-Ilankovic, L., Ruhrmann, S., Rosen, M., Ruef, A., Dwyer, D. B., Paolini, M., Chisholm, K., Kambeitz, J., Haidl, T., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2165 · Cited by 341
Towards a youth mental health paradigm: a perspective and roadmap
Uhlhaas, P. J., Davey, C. G., Mehta, U. M., Shah, J., Torous, J., Allen, N. B., Avenevoli, S., Bella-Awusah, T., Chanen, A., Chen, E. Y. H., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02202-z · Cited by 318
“There is evidence that clinical [81], cognitive [82], and neuroimaging measures [83] constitute possible biomarkers that signi fi cantly increase accuracy for predicting clinical outcomes in CHR-P participants.”
BackgroundValidity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum
Kotov, R., Jonas, K. G., Carpenter, W. T., Dretsch, M. N., Eaton, N. R., Forbes, M. K., Forbush, K. T., Hobbs, K., Reininghaus, U., Slade, T., et al. (2020) · World Psychiatry · doi:10.1002/wps.20730 · Cited by 309
Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review
Murray, G. K., Lin, T., Austin, J., McGrath, J. J., Hickie, I. B., & Wray, N. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3042 · Cited by 275
Koutsouleris, N., Dwyer, D. B., Degenhardt, F., Maj, C., Urquijo-Castro, M. F., Sanfelici, R., Popovic, D., Oeztuerk, O., Haas, S. S., Weiske, J., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3604 · Cited by 275
Seidman, L. J., Shapiro, D. I., Stone, W. S., Woodberry, K. A., Ronzio, A., Cornblatt, B. A., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2479 · Cited by 270
Self-citationNeuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Cassidy, C. M., Zucca, F. A., Girgis, R. R., Baker, S. C., Weinstein, J. J., Sharp, M. E., Bellei, C., Valmadre, A., Vanegas, N., Kegeles, L. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807983116 · Cited by 244
“Such a biomarker could further help select a subset of at-risk individuals who, more so than CHR individuals as a whole (58, 59), may benefit from antidopaminergic medication, thus augmenting current risk-prediction algorithms based solely on nonbiological measures (60).”
BackgroundZheutlin, A. B., Dennis, J., Karlsson Linnér, R., Moscati, A., Restrepo, N., Straub, P., Ruderfer, D., Castro, V. M., Chen, C.-Y., Ge, T., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091085 · Cited by 223
Salazar de Pablo, G., Studerus, E., Vaquerizo-Serrano, J., Irving, J., Catalan, A., Oliver, D., Baldwin, H., Danese, A., Fazel, S., Steyerberg, E. W., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa120 · Cited by 219
The Clinical High-Risk State for Psychosis (CHR-P), Version II
Fusar-Poli, P. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw158 · Cited by 217
Catalan, A., Salazar de Pablo, G., Aymerich, C., Damiani, S., Sordi, V., Radua, J., Oliver, D., McGuire, P., Giuliano, A. J., Stone, W. S., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1290 · Cited by 217
Ni, G., Zeng, J., Revez, J. A., Wang, Y., Zheng, Z., Ge, T., Restuadi, R., Kiewa, J., Nyholt, D. R., Coleman, J. R. I., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.018 · Cited by 203
“Nonetheless, PGSs in combination with clinical risk factors could make a useful contribution to risk prediction (35 – 37).”
Mayo, D., Corey, S., Kelly, L. H., Yohannes, S., Youngquist, A. L., Stuart, B. K., Niendam, T. A., & Loewy, R. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00055 · Cited by 200
“Trauma appears to predict conversion to psychosis, but may not function independently of other known risk factors such as more severe positive symptoms, cognition, and functioning (16).”
BackgroundThe Science of Prognosis in Psychiatry: A Review
Fusar-Poli, P., Hijazi, Z., Stahl, D., & Steyerberg, E. W. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2530 · Cited by 197
Language as a biomarker for psychosis: a natural language processing approach
Corcoran, C. M., Mittal, V. A., Bearden, C. E., E. Gur, R., Hitczenko, K., Bilgrami, Z., Savic, A., Cecchi, G. A., & Wolff, P. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.032 · Cited by 186
“, 2012); these cognitive domains also are part of the NAPLS risk calculator for psychosis onset (Cannon et al., 2016).”
BackgroundSelf-citationSullivan, S. A., Kounali, D., Cannon, M., David, A. S., Fletcher, P. C., Holmans, P., Jones, H., Jones, P. B., Linden, D. E. J., Lewis, G., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19060654 · Cited by 176
“The predictive ability of these measures may well be improved by utilising additional information on functional decline, cognitive ability, and other biomarkers of early transitioning to psychosis (44, 45).”
BackgroundHafeman, D. M., Merranko, J., Goldstein, T. R., Axelson, D., Goldstein, B. I., Monk, K., Hickey, M. B., Sakolsky, D., Diler, R., Iyengar, S., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1763 · Cited by 173
Self-citationCarrión, R. E., Cornblatt, B. A., Burton, C. Z., Tso, I. F., Auther, A. M., Adelsheim, S., Calkins, R., Carter, C. S., Niendam, T., Sale, T. G., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15121565 · Cited by 170
Self-citationA systematic review of metabolite biomarkers of schizophrenia
Davison, J., O'Gorman, A., Brennan, L., & Cotter, D. R. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.021 · Cited by 160
“Clinical characteristics alone are of limited predictive value and therefore biological predictors of schizophrenia and of the psychosis prodrome will be of enormous value (Cannon et al., 2016; Chan et al., 2015; Weickert et al., 2013).”
BackgroundOliver, D., Reilly, T. J., Baccaredda Boy, O., Petros, N., Davies, C., Borgwardt, S., McGuire, P., & Fusar-Poli, P. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz039 · Cited by 163
Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
Lieberman, J. A., Small, S. A., & Girgis, R. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19080865 · Cited by 160
Chung, Y., Addington, J., Bearden, C. E., Cadenhead, K., Cornblatt, B., Mathalon, D. H., McGlashan, T., Perkins, D., Seidman, L. J., Tsuang, M., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.1543 · Cited by 150
Self-citationChildhood trauma and clinical high risk for psychosis
Loewy, R. L., Corey, S., Amirfathi, F., Dabit, S., Fulford, D., Pearson, R., Hua, J. P. Y., Schlosser, D., Stuart, B. K., Mathalon, D. H., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.003 · Cited by 130
“Finally, a critical avenue of investigation is whether CT raises the risk for transition to psychosis and other poor outcomes within the CHR population, which has not yet been unequivocally established (Bechdolf et al., 2010; Cannon et al., 2016; Stowkowy et al., 2016; Yung et al., 2015).”
Self-citationPerkins, D. O., Olde Loohuis, L., Barbee, J., Ford, J., Jeffries, C. D., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18060721 · Cited by 123
Self-citationBrain Subtyping Enhances The Neuroanatomical Discrimination of Schizophrenia
Dwyer, D. B., Cabral, C., Kambeitz-Ilankovic, L., Sanfelici, R., Kambeitz, J., Calhoun, V., Falkai, P., Pantelis, C., Meisenzahl, E., & Koutsouleris, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby008 · Cited by 114
Addington, J., Stowkowy, J., Liu, L., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718002258 · Cited by 110
“…be predictive of later transition to psychosis, suggesting that these are the cognitive functions most likely to be impaired for those at CHR (Cornblatt et al., 2015; Addington et al., 2016; Cannon et al., 2016) and perhaps ones that could be addressed in terms of remediation (Choi et al., 2017).”
Self-citationPreventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00764 · Cited by 108
Davies, C., Radua, J., Cipriani, A., Stahl, D., Provenzani, U., McGuire, P., & Fusar-Poli, P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00187 · Cited by 107
Carrión, R. E., Auther, A. M., McLaughlin, D., Olsen, R., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Mathalon, D. H., McGlashan, T. H., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby126 · Cited by 105
Self-citationNorth American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description
Addington, J., Liu, L., Brummitt, K., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Keshavan, M. S., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.010 · Cited by 115
“This was known as “enhanced criteria” and was based on the Risk Calculator designed from NAPLS 2 (Cannon et al., 2016).”
BackgroundMethodSelf-citationMongan, D., Föcking, M., Healy, C., Susai, S. R., Heurich, M., Wynne, K. J., Nelson, B., McGorry, P. D., Amminger, G. P., Nordentoft, M., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2459 · Cited by 110
Fusar-Poli, P., Werbeloff, N., Rutigliano, G., Oliver, D., Davies, C., Stahl, D., McGuire, P., & Osborn, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby070 · Cited by 95
From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline
Carrión, R. E., Walder, D. J., Auther, A. M., McLaughlin, D., Zyla, H. O., Adelsheim, S. N., Calkins, R., Carter, C. S., McFarland, B. H., Melton, R. P., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.10.014 · Cited by 108
Self-citationFusar-Poli, P., Sullivan, S. A., Shah, J. L., & Uhlhaas, P. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00774 · Cited by 92
“This is a substantial advantage compared with the current CHR-P strategy, which is limited by group-level prediction, at risk or not at risk, with few exceptions such as the risk calculator by Cannon et al (58, 59).”
MethodResultIs It Possible to Predict the Future in First-Episode Psychosis?
Suvisaari, J., Mantere, O., Keinänen, J., Mäntylä, T., Rikandi, E., Lindgren, M., Kieseppä, T., & Raij, T. T. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00580 · Cited by 87
“As an example, a risk calculator for predicting the psychosis conversion risk in patients with a clinical high-risk state was recently published (181).”
BackgroundInfluentialMcDonald, M., Christoforidou, E., Van Rijsbergen, N., Gajwani, R., Gross, J., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze-Lutter, F., & Uhlhaas, P. J. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby069 · Cited by 86
Natural Language Processing markers in first episode psychosis and people at clinical high-risk
Morgan, S. E., Diederen, K. M. J., Vértes, P. E., Ip, S., Wang, B., Thompson, B., Demjaha, A., Micheli, A. D., Oliver, D., Liakata, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01722-y · Cited by 109
Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis
Addington, J., Addington, D., Abidi, S., Raedler, T., & Remington, G. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717719895 · Cited by 83
“There is now an individualised risk calculator that can improve prediction in the situation that the individuals at clinical high risk are help seeking and have been diagnosed using the Structured Clinical Interview for Prodromal State.(22)”
MethodSelf-citationEvolving Notions of Schizophrenia as a Developmental Neurocognitive Disorder
Seidman, L. J., & Mirsky, A. F. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717001114 · Cited by 95
“Moreover, the use of neurocognitive measures in prediction algorithms, such as “risk calculators” (Cannon et al., 2016), may bring us closer to predicting and preventing schizophrenia.”
Self-citationHamilton, H., Woods, S. W., Roach, B. J., Llerena, K., McGlashan, T. H., Srihari, V. H., Ford, J. M., & Mathalon, D. H. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby167 · Cited by 89
Self-citationZhang, T., Xu, L., Tang, Y., Li, H., Tang, X., Cui, H., Wei, Y., Wang, Y., Hu, Q., Liu, X., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718002738 · Cited by 82
“Moreover, the accuracy of the SIPS-RC reported in this study (AUC = 0.74) is comparable with the results of previous studies developing and evaluating the performance of the NAPLS-2 calculator (0.71 and 0.79, respectively) (Cannon et al., 2016; Carrion et al., 2016).”
MethodResultSelf-citationSanfelici, R., Dwyer, D. B., Antonucci, L. A., & Koutsouleris, N. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.009 · Cited by 82
“Multimodal approaches included different combinations of clinical, neuropsychological, and demographic variables as well as genetic risk (28,51,52,54,74).”
‘At risk mental state’ clinics for psychosis – an idea whose time has come – and gone!
Ajnakina, O., David, A. S., & Murray, R. M. (2019) · Psychological Medicine · doi:10.1017/s0033291718003859 · Cited by 82
The Maudsley environmental risk score for psychosis
Vassos, E., Sham, P. C., Kempton, M. J., Trotta, A., Stilo, S. A., Gayer-Anderson, C. E., Forti, M. D., Lewis, C. M., Murray, R. M., & Morgan, C. (2019) · Psychological Medicine · doi:10.1017/s0033291719002319 · Cited by 94
“Other existing risk calculators focus on the prediction of psychosis among individuals who have already developed a prodromal risk syndrome (Cannon et al., 2016; Carrion et al., 2016) or patients accessing secondary mental health care (Fusar-Poli et al.”
Birmaher, B., Merranko, J. A., Goldstein, T. R., Gill, M. K., Goldstein, B. I., Hower, H., Yen, S., Hafeman, D., Strober, M., Diler, R. S., et al. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.05.023 · Cited by 81
Ho, N. F., Holt, D. J., Cheung, M. W. ‐., Iglesias, J. E., Goh, A., Wang, M., Lim, J. K. W., de Souza, J., Poh, J. S., See, Y. M., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.5 · Cited by 85
“(Cannon et al, 2008; Yung et al, 2003), although they are similar to recent at-risk cohorts across multiple worldwide sites (Cannon et al, 2016; Carrion et al, 2016; Ruhrmann et al, 2010); indeed, rates of conversion have been steadily declining over the past decade to ~ 7–15% (FusarPoli et al,…”
ResultShah, J. L., Crawford, A., Mustafa, S. S., Iyer, S. N., Joober, R., & Malla, A. K. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600304 · Cited by 80
Tognin, S., van Hell, H. H., Merritt, K., Winter-van Rossum, I., Bossong, M. G., Kempton, M. J., Modinos, G., Fusar-Poli, P., Mechelli, A., Dazzan, P., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz067 · Cited by 78
Brucato, G., Masucci, M. D., Arndt, L. Y., Ben-David, S., Colibazzi, T., Corcoran, C. M., Crumbley, A. H., Crump, F. M., Gill, K. E., Kimhy, D., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291717000319 · Cited by 77
Pries, L.-K., Gülöksüz, S., ten Have, M., de Graaf, R., van Dorsselaer, S., Günther, N., Rauschenberg, C., Reininghaus, U., Radhakrishnan, R., Bak, M., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby051 · Cited by 83
Vargas, T., Lam, P. H., Azis, M., Osborne, K. J., Lieberman, A., & Mittal, V. A. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby150 · Cited by 75
Goldsmith, D. R., Haroon, E., Miller, A. H., Addington, J., Bearden, C. E., Cadenhead, K., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.315 · Cited by 84
Self-citationVoineskos, A. N., Hawco, C. S., Neufeld, N. H., Turner, J. A., Ameis, S. H., Anticevic, A., Buchanan, R. W., Cadenhead, K. S., Dazzan, P., Dickie, E. W., et al. (2024) · World Psychiatry · doi:10.1002/wps.21159 · Cited by 94
Self-citationResilience as a translational endpoint in the treatment of PTSD
Rakesh, G., Morey, R. A., Zannas, A. S., Malik, Z., Marx, C. E., Clausen, A. N., Kritzer, M. D., & Szabo, S. T. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0383-7 · Cited by 80
Hamilton, H., Roach, B. J., Bachman, P., Belger, A., Carrión, R. E., Duncan, E., Johannesen, J., Light, G. A., Niznikiewicz, M. A., Addington, J., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.1417 · Cited by 76
Self-citationZhang, T., Li, H., Tang, Y., Niznikiewicz, M. A., Shenton, M. E., Keshavan, M. S., Stone, W. S., McCarley, R. W., Seidman, L. J., & Wang, J. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18010036 · Cited by 71
Self-citationCollins, M. A., Ji, J. L., Chung, Y., Lympus, C. A., Afriyie-Agyemang, Y., Addington, J., Goodyear, B. G., Bearden, C. E., Cadenhead, K. S., Mirzakhanian, H., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01870-7 · Cited by 75
Self-citationPredictors of Transition to Psychosis in Individuals at Clinical High Risk
Addington, J., Farris, M. S., Stowkowy, J., Santesteban‐Echarri, O., Metzak, P. D., & Kalathil, M. S. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1027-y · Cited by 80
Self-citationInflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology
Miller, B. J., & Goldsmith, D. R. (2019) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2019.100006 · Cited by 68
Disorganized Gyrification Network Properties During the Transition to Psychosis
Das, T. K., Borgwardt, S., Hauke, D. J., Harrisberger, F., Lang, U. E., Riecher‐Rössler, A., Palaniyappan, L. K., & Schmidt, A. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0391 · Cited by 74
Sydnor, V. J., & Roalf, D. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.028 · Cited by 67
Hamilton, H., Boos, A. K., & Mathalon, D. H. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.04.002 · Cited by 73
“While algorithms predicting these outcomes using clinical and cognitive data have been developed and validated (5,6), they are not yet sufficiently accurate to support major treatment decisions such as whether antipsychotic medication should be initiated.”
BackgroundMethodSelf-citationLabad, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.028 · Cited by 72
Bolt, L. K., Amminger, G. P., Farhall, J., McGorry, P. D., Nelson, B., Markulev, C., Yuen, H. P., Schäfer, M. R., Mossaheb, N., Schlögelhofer, M., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.013 · Cited by 72
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
Khoury, R., & Nasrallah, H. A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.04.017 · Cited by 71
Emotion regulation across the psychosis continuum
Chapman, H. C., Visser, K. F., Mittal, V. A., Gibb, B. E., Coles, M. E., & Strauss, G. P. (2020) · Development and Psychopathology · doi:10.1017/s0954579418001682 · Cited by 64
“Reflective of these signs, approximately 15%–30% of CHR individuals will transition to a psychotic disorder within 2 years (Cannon et al., 2008; Cannon et al., 2016; Fusar-Poli et al., 2015).”
BackgroundPeh, O. H., Rapisarda, A., & Lee, J. (2019) · Psychological Medicine · doi:10.1017/s003329171800394x · Cited by 61
“…of several predictors (social functioning, verbal learning, cognition, age, stressful life events, family history of psychosis, traumas) were analysed in multivariate cox regressions, childhood trauma and family history of psychosis were not significant in predicting TTP (Cannon et al., 2016).”
BackgroundMethodInfluentialMoritz, S., Gawęda, Ł., Heinz, A., & Gallinat, J. (2019) · Psychological Medicine · doi:10.1017/s0033291719001740 · Cited by 64
“Although ‘risk calculators’ have been developed to increase predictive accuracy (Cannon et al., 2016; Fusar-Poli, 2017), these are based on retrospective group data and have not been readily validated for predictive purposes.”
BackgroundMismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia
Hamilton, H. K., Perez, V. B., Ford, J. M., Roach, B. J., Jaeger, J., & Mathalon, D. H. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx104 · Cited by 58
Self-citationKoutsouleris, N., Worthington, M., Dwyer, D., Kambeitz‐Ilankovic, L., Sanfelici, R., Fusar‐Poli, P., Rosen, M., Ruhrmann, S., Anticevic, A., Addington, J., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.06.023 · Cited by 62
Self-citationTang, Y., Wang, J., Zhang, T., Xu, L. N., Qian, Z., Cui, H., Tang, X. Y., Whitfield‐Gabrieli, S., Whitfield, S., Shenton, M. E., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.02.014 · Cited by 67
“As we included a larger sample than previous studies, the inconsistency may be due to the heterogeneity of CHR samples (Nieman et al., 2014; Kim et al., 2015; Cannon et al., 2016).”
BackgroundResultSelf-citationProgression from being at-risk to psychosis: next steps
Addington, J., Farris, M. S., Devoe, D. J. A., & Metzak, P. D. (2020) · Schizophrenia · doi:10.1038/s41537-020-00117-0 · Cited by 61
Self-citationDean, D. J., Walther, S., Bernard, J. A., & Mittal, V. A. (2018) · Clinical Psychological Science · doi:10.1177/2167702618773759 · Cited by 59
“To address this limitation in analyses and subsequent interpretation of psychosis risk in this study, we also employed an additional continuous measure of psychosis risk using a freely available online calculator (http://riskcalc.org:3838/ napls/) recently developed by the North American Prodrome Longitudinal Study (N…”
BackgroundMethodInfluentialNelson, B., Amminger, G. P., Yuen, H. P., Markulev, C., Lavoie, S., Schäfer, M. R., Hartmann, J., Mossaheb, N., Schlögelhofer, M., Smesny, S., et al. (2018) · Schizophrenia · doi:10.1038/s41537-018-0052-x · Cited by 60
Riecher-Rössler, A., & Studerus, E. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000320 · Cited by 55
Kline, E. R., Seidman, L. J., Cornblatt, B. A., Woodberry, K. A., Bryant, C., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Mathalon, D. H., McGlashan, T. H., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.032 · Cited by 53
“This work complements recent research establishing individualized risk prediction from clinical and neuropsychological factors that can easily be assessed in individuals meeting SIPS criteria for high risk states (see Cannon et al., 2016; Carrión et al., 2016).”
BackgroundSelf-citationFöcking, M., Sabherwal, S., Cates, H. M., Scaife, C., Dicker, P., Hryniewiecka, M., Wynne, K. J., Rutten, B. P. F., Lewis, G., Cannon, M. D., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0306-z · Cited by 58
Allswede, D. M., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T., Perkins, D. O., Seidman, L. J., Tsuang, M. T., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18111290 · Cited by 54
“However, other prediction approaches have been developed for conversion (3) that are complementary to the present approach, and together these tools capture a wider range of the outcomes of help-seeking clinical high-risk individuals.”
BackgroundSelf-citationA predictive model for conversion to psychosis in clinical high-risk patients
Ciarleglio, A., Brucato, G., Masucci, M. D., Altschuler, R., Colibazzi, T., Corcoran, C. M., Crump, F. M., Horga, G., Lehembre-Shiah, E., Leong, W., et al. (2018) · Psychological Medicine · doi:10.1017/s003329171800171x · Cited by 57
“Figure 2 provides ROC curves for the present model (in-sample) and from published (in-sample) values from the NAPLS study [Table 3 in the original publication (Cannon et al., 2016)].”
BackgroundMethodResultInfluentialGawęda, Ł., Göritz, A. S., & Moritz, S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.11.034 · Cited by 52
Woods, S. W., Parker, S., Kerr, M., Walsh, B. C., Wijtenburg, S. A., Prunier, N., Núñez, Á., Buccilli, K., Mourgues, C., Brummitt, K., et al. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13457 · Cited by 71
“No procedure could be devised to harmonize the two instruments by reorganizing content into just a handful of items without losing the integrity of individual items that have been strongly predictive of future psychosis in previous studies (Cannon et al., 2016).”
Self-citationOliver, D., Arribas, M., Radua, J., Salazar de Pablo, G., De Micheli, A., Spada, G., Mensi, M. M., Kotlicka-Antczak, M., Borgatti, R., Solmi, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01611-w · Cited by 49
“proteomics [75], neuroimaging [76] and clinical/neurocognitive [77] data).”
Self-citationOliver, D., Spada, G., Colling, C., Broadbent, M., Baldwin, H., Patel, R., Stewart, R., Stahl, D., Dobson, R., McGuire, P., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.007 · Cited by 49
Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry
Miller, A. H., Berk, M., Bloch, G., Briquet-Laugier, V., Brouillon, C., Cuthbert, B. N., Dantzer, R., Davis, M. C., Picker, L. D., Drevets, W. C., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.002 · Cited by 60
Leighton, S. P., Upthegrove, R., Krishnadas, R., Benros, M. E., Broome, M. R., Gkoutos, G. V., Liddle, P. F., Singh, S. P., Everard, L., Jones, P. B., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30121-9 · Cited by 49
“…and recovery (social and vocational recovery and QoL), in recognition of the fact that intervention strategies might be distinct for each outcome, 31 even though each of our models was able to accurately predict other outcomes significantly better than chance, albeit with reduced performance.”
ResultFoss‐Feig, J. H., Velthorst, E., Smith, L., Reichenberg, A., Addington, J., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., et al. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.09.446 · Cited by 49
Self-citationAntonucci, L. A., Pergola, G., Pigoni, A., Dwyer, D., Kambeitz‐Ilankovic, L., Penzel, N., Romano, R., Gelao, B., Torretta, S., Rampino, A., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.11.007 · Cited by 49
Kafadar, E., Mittal, V. A., Strauss, G. P., Chapman, H. C., Ellman, L. M., Bansal, S., Gold, J. M., Alderson‐Day, B., Evans, S., Moffatt, J. A., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.017 · Cited by 57
“, 2016) and the use of clinical measures alone, while promising, is nonetheless limited inpredicting course and triggering treatment initiation (Cannon et al., 2016; Carrion et al., 2016).”
BackgroundSelf-citationLongitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome
Tang, S. X., & Gur, R. E. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38500 · Cited by 54
“…to psychosis among individuals at elevated clinical risk by higher levels of unusual thought content and suspiciousness, greater decline in social functioning, younger baseline age, and impairments in verbal learning, memory, and processing speed (Cannon et al., 2016; Carrión et al., 2016).”
BackgroundMeehan, A. J., Latham, R. M., Arseneault, L., Stahl, D. R., Fisher, H. L., & Danese, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.034 · Cited by 56
“, 2018), as well as recently-developed prediction models in psychiatry (Cannon et al., 2016; Fusar-Poli et al., 2017; Hafeman et al., 2017).”
BackgroundCollin, G., Nieto-Castañón, A., Shenton, M. E., Pasternak, O., Kelly, S., Keshavan, M. S., Seidman, L. J., McCarley, R. W., Niznikiewicz, M. A., Li, H., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102108 · Cited by 50
“Clinical predictor selection As clinical predictors, we selected variables included in the psychosis-risk calculator developed for the CHR stage (Cannon et al., 2016) and validated in the SHARP study (Zhang et al.”
InfluentialSelf-citationPredictors of transition in patients with clinical high risk for psychosis: an umbrella review
Andreou, C., Eickhoff, S., Heide, M., de Bock, R., Obleser, J., & Borgwardt, S. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02586-0 · Cited by 57
“Large samples and harmonization of methods are necessary to overcome the limitations of a currently still very heterogeneous fi eld of research.”
BackgroundCui, H., Giuliano, A. J., Zhang, T., Xu, L., Wei, Y., Tang, Y., Qian, Z., Stone, L., Li, H., Whitfield, S., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.018 · Cited by 48
Metadata
- Authors
- Cannon, T. D., Yu, C., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Heinssen, R., Jeffries, C. D., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., Woods, S. W., & Kattan, M. W.
- Affiliations
- Cleveland Clinic (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2016-10-01
- Volume
- 173
- Issue
- 10
- Pages
- 980-988
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC5048498
- OpenAlex
- W2466834759
- Cited by
- 574
- References
- 41
- Citations by year
- 2026: 21 · 2025: 54 · 2024: 40 · 2023: 63 · 2022: 49 · 2021: 52 · 2020: 75 · 2019: 97 · 2018: 69 · 2017: 39 · 2016: 15
- FWCI
- 65.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR001863)
- National Institute of Mental Health (U01MH066134, U01MH081928, U01MH081902, U01MH082022, U01MH066069, U01MH076989, R01MH076989, U01MH081984, U01MH081857, U01MH082004, U01MH081944, P50MH066286, U01MH081988)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- prodromal psychosis, clinical high risk for psychosis, transition to psychosis, risk prediction, unusual thought content, suspicion, verbal learning and memory, processing speed, age of onset, North American Prodrome Longitudinal Study
- MeSH terms
- Adolescent, Humans, Longitudinal Studies, Predictive Value of Tests, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Early Diagnosis, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.